Merck’s 23 immune & oncology pipelines accelerated towards commercialization
Merck, a global pharmaceutical company, showed a strong will to develop new drugs related to oncology by revealing immune and oncology pipelines being developed by the company.
Professor Morihiro Watanabe taking in charge of the clinical development of Merch Serono introduced the company’s immun...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.